|Mr. Charles D. Goodwin II||Pres, CEO & Director||1.49M||N/A||1966|
|Ms. Tara H. Semb||CFO, Treasurer & Sec.||N/A||N/A||1970|
|Mr. Moshe Citronowicz||Sr. VP||588.32k||N/A||1953|
|Mr. Todd Hornsby||Exec. VP||504.1k||N/A||1976|
Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide. The company markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. Its Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.